Abstract

We report that cryoablation of primary tumors synergizes with anti-CTLA-4 treatment to mediate rejection of secondary tumors in the TRAMP mouse model of prostate cancer. T cells, in particular CD8(+) T cells specific for the TRAMP antigen SPAS-1, were enriched in both secondary tumors and spleens of combination-treated mice.

Keywords

CryoablationBlockadeTrampCancer researchCD8MedicineProstate cancerImmunotherapyAntigenCancerImmunologyImmune systemInternal medicineReceptor

Affiliated Institutions

Related Publications

Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 but Also Interphotoreceptor Retinoid Binding Protein–Specific Th1 by Promoting Regulatory T Cells in Experimental Autoimmune Uveoretinitis

PURPOSE. Both Th17 and Th1 cells contribute to experimental autoimmune uveoretinitis (EAU). Interleukin-6 (IL-6) blockade inhibits Th17 differentiation in EAU and potently suppr...

2011 Investigative Ophthalmology & Visual ... 73 citations

Publication Info

Year
2012
Type
article
Volume
1
Issue
4
Pages
544-546
Citations
33
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

33
OpenAlex

Cite This

Rebecca Waitz, Marcella Fassò, James P. Allison (2012). CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection. OncoImmunology , 1 (4) , 544-546. https://doi.org/10.4161/onci.19442

Identifiers

DOI
10.4161/onci.19442